US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEUROGENE INC

39.64

+1.012.61%

Volume:439.10K

Turnover:17.35M

Market Cap:793.25M

PE:-7.86

High:40.82

Open:38.64

Low:37.50

Close:38.63

52wk High:43.66

52wk Low:15.93

Shares:20.01M

Float Shares:11.34M

Volume Ratio:2.12

T/O Rate:3.87%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.0440

EPS(LYR):-4.2400

ROE:-45.32%

ROA:-27.97%

PB:3.65

PE(LYR):-9.35

Loading ...

Overview Company News Filings

Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome

THOMSON REUTERS

Neurogene - Ngn-401 Generally Well-tolerated at 1E15 Vg Dose as of June 16, 2026

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE)

Neurogene Price Target Maintained With a $70.00/Share by HC Wainwright & Co.

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Lyell Immunopharma (LYEL)

Neurogene Completes Enrollment in Embolden Trial of NGN-401

MT Newswires Live

Neurogene - Topline Data From Embolden Trial Anticipated in Second Half of 2027 - SEC Filing

THOMSON REUTERS

Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of Ngn-401 for Rett Syndrome

THOMSON REUTERS

Neurogene shareholders elect Baffi, Palekar as Class III directors

Neurogene initiated with a Buy at Rodman & Renshaw

Neurogene issues inducement stock options for 17,045 shares to new hires

Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)

LifeSci Capital Sticks to Its Buy Rating for Neurogene (NGNE)

Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), Neurogene (NGNE)

Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)

Neurogene Q1 EPS $(1.39) Misses $(1.36) Estimate

Benzinga Earnings

Neurogene posts corporate deck highlighting NGN-401 gene therapy program for Rett syndrome

Neurogene Q1 net loss widens on higher R&D costs

Neurogene Q1 FY26 net loss widens to USD 30.9 million

BRIEF-Neurogene Q1 Operating Expenses USD 33.349 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NGNE/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NGNE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","market":"US","secType":"STK","nameCN":"NEUROGENE INC","latestPrice":39.64,"timestamp":1787601600000,"preClose":38.63,"halted":0,"volume":439100,"delay":0,"changeRate":0.026145482785399896,"floatShares":11340900,"shares":20011400,"eps":-5.044019,"marketStatus":"Pre-Mkt","change":1.01,"latestTime":"08-25 07:57:29 EDT","open":38.64,"high":40.82,"low":37.5,"amount":17354126.8858,"amplitude":0.085944,"askPrice":40,"askSize":121,"bidPrice":32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.044019,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"listingDate":1394168400000,"exchange":"NASDAQ","adjPreClose":39.64,"postHourTrading":{"tag":"盘后","latestPrice":39.64,"preClose":39.64,"latestTime":"19:30 EDT","volume":1150,"amount":45586.32,"timestamp":1787614204252,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.1234163830877817,"impliedVol":0.8102,"impliedVolPercentile":0.296},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NGNE\",,,,,undefined,":{"symbol":"NGNE","floatShares":11340900,"roa":"-27.97%","roe":"-45.32%","lyrEps":-4.24,"volumeRatio":2.1234163830877817,"shares":20011400,"dividePrice":0,"high":40.82,"amplitude":0.085944,"preClose":38.63,"low":37.5,"week52Low":15.93,"pbRate":"3.65","week52High":43.66,"institutionHeld":0,"latestPrice":39.64,"committee":-0.095023,"eps":-5.044019,"divideRate":0,"volume":439100,"delay":0,"ttmEps":-5.044019,"open":38.64,"prevYearClose":20.6,"prevWeekClose":38.63,"prevMonthClose":32.89,"prevQuarterClose":31.45,"fiveDayClose":36.68,"twentyDayClose":34.62,"sixtyDayClose":27.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NGNE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-11","symbol":"NGNE","fiscalQuarterEnding":"2026/06","expectedEps":-1.4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786420800000,"reportTimeType":"pre","actualEps":-1.53},{"market":"US","date":"2026-05-12","symbol":"NGNE","fiscalQuarterEnding":"2026/03","expectedEps":-1.35,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778558400000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2026-03-24","symbol":"NGNE","fiscalQuarterEnding":"2025/12","expectedEps":-1.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774324800000,"reportTimeType":"pre","actualEps":-1.12},{"market":"US","date":"2025-11-13","symbol":"NGNE","fiscalQuarterEnding":"2025/09","expectedEps":-1.26,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.99},{"market":"US","date":"2025-08-11","symbol":"NGNE","fiscalQuarterEnding":"2025/06","expectedEps":-1.15,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":-1.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NGNE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NGNE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4444,"buy":0.5556,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1777608000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NGNE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NGNE","date":"2026-08-21","current":-7.858813,"percent":0.350932,"low":-19.523035,"twenty":-9.89127,"median":-4.877395,"eighty":-3.468013,"high":-1.458307,"avg":-6.459544,"sd":3.696345,"marketCap":760232402},"quantilePoints":[{"date":"2023-12-29","current":-4.323556,"twenty":-4.185645,"median":-3.978778,"eighty":-3.916869,"marketCap":220311097},{"date":"2024-01-05","current":-5.423319,"twenty":-5.000527,"median":-4.624292,"eighty":-3.978778,"marketCap":276350648},{"date":"2024-01-12","current":-8.005373,"twenty":-7.157271,"median":-5.423319,"eighty":-4.323556,"marketCap":407921769},{"date":"2024-01-19","current":-7.59768,"twenty":-7.599292,"median":-7.086806,"eighty":-4.804734,"marketCap":387147382},{"date":"2024-01-26","current":-8.053188,"twenty":-7.611677,"median":-7.561189,"eighty":-4.985427,"marketCap":410358272},{"date":"2024-02-02","current":-7.741127,"twenty":-7.937424,"median":-7.577547,"eighty":-5.338761,"marketCap":394456888},{"date":"2024-02-09","current":-7.497015,"twenty":-7.980207,"median":-7.59013,"eighty":-6.388695,"marketCap":382017903},{"date":"2024-02-16","current":-7.549864,"twenty":-7.937424,"median":-7.577547,"eighty":-6.995453,"marketCap":384710880},{"date":"2024-02-23","current":-7.622846,"twenty":-7.894138,"median":-7.57503,"eighty":-7.129085,"marketCap":388429751},{"date":"2024-03-01","current":-7.819143,"twenty":-7.894138,"median":-7.588872,"eighty":-7.262969,"marketCap":398432234},{"date":"2024-03-08","current":-9.734292,"twenty":-8.024499,"median":-7.59768,"eighty":-7.381754,"marketCap":496020561},{"date":"2024-03-15","current":-8.697444,"twenty":-8.083388,"median":-7.629138,"eighty":-7.463796,"marketCap":443186933},{"date":"2024-03-22","current":-17.419498,"twenty":-9.10262,"median":-7.660596,"eighty":-7.498525,"marketCap":632623921},{"date":"2024-03-28","current":-17.433655,"twenty":-9.373408,"median":-7.741127,"eighty":-7.499532,"marketCap":633138041},{"date":"2024-04-05","current":-15.090764,"twenty":-9.721205,"median":-7.845567,"eighty":-7.510605,"marketCap":548051280},{"date":"2024-04-12","current":-13.565408,"twenty":-14.180505,"median":-7.97769,"eighty":-7.536275,"marketCap":492654915},{"date":"2024-04-19","current":-11.176509,"twenty":-13.912948,"median":-8.029281,"eighty":-7.549864,"marketCap":405897266},{"date":"2024-04-26","current":-10.571321,"twenty":-13.650346,"median":-8.053188,"eighty":-7.549864,"marketCap":383918661},{"date":"2024-05-03","current":-12.537284,"twenty":-13.442874,"median":-8.146303,"eighty":-7.558924,"marketCap":455316556},{"date":"2024-05-10","current":-11.764996,"twenty":-13.2542,"median":-9.074937,"eighty":-7.57352,"marketCap":427269365},{"date":"2024-05-17","current":-10.587696,"twenty":-13.13876,"median":-9.272492,"eighty":-7.576037,"marketCap":433830864},{"date":"2024-05-24","current":-9.887502,"twenty":-12.800854,"median":-9.44488,"eighty":-7.581574,"marketCap":405140389},{"date":"2024-05-31","current":-10.685033,"twenty":-12.52136,"median":-9.620612,"eighty":-7.588117,"marketCap":437819226},{"date":"2024-06-07","current":-11.771752,"twenty":-12.409114,"median":-9.810897,"eighty":-7.59013,"marketCap":482347539},{"date":"2024-06-14","current":-13.301826,"twenty":-12.457666,"median":-9.93146,"eighty":-7.59013,"marketCap":545042335},{"date":"2024-06-21","current":-9.842528,"twenty":-12.564112,"median":-9.93146,"eighty":-7.59617,"marketCap":403297579},{"date":"2024-06-28","current":-11.030474,"twenty":-12.52136,"median":-10.019377,"eighty":-7.599292,"marketCap":451973662},{"date":"2024-07-05","current":-11.397945,"twenty":-12.537284,"median":-10.188931,"eighty":-7.605739,"marketCap":467030798},{"date":"2024-07-12","current":-13.232134,"twenty":-12.537284,"median":-10.458961,"eighty":-7.622846,"marketCap":542186671},{"date":"2024-07-15","current":-13.48873,"twenty":-12.644595,"median":-10.463671,"eighty":-7.625363,"marketCap":552700705},{"date":"2024-08-02","current":-12.832984,"twenty":-12.76836,"median":-10.468381,"eighty":-7.627879,"marketCap":525831507},{"date":"2024-08-09","current":-11.578513,"twenty":-12.617767,"median":-10.579508,"eighty":-7.644992,"marketCap":474429562},{"date":"2024-08-16","current":-9.721942,"twenty":-12.533918,"median":-10.468381,"eighty":-7.659841,"marketCap":462832495},{"date":"2024-08-23","current":-9.22793,"twenty":-12.500388,"median":-10.20777,"eighty":-7.686769,"marketCap":439314055},{"date":"2024-08-30","current":-9.934831,"twenty":-12.3607,"median":-10.082175,"eighty":-7.732068,"marketCap":472967513},{"date":"2024-09-06","current":-9.383503,"twenty":-12.215183,"median":-10.030358,"eighty":-7.751697,"marketCap":446720414},{"date":"2024-09-13","current":-11.015654,"twenty":-12.198503,"median":-10.056266,"eighty":-7.799009,"marketCap":524422220},{"date":"2024-09-20","current":-11.343175,"twenty":-12.111032,"median":-10.20463,"eighty":-7.829713,"marketCap":540014556},{"date":"2024-09-27","current":-10.69359,"twenty":-12.018852,"median":-10.282823,"eighty":-7.883065,"marketCap":509089757},{"date":"2024-10-04","current":-12.12104,"twenty":-12.018852,"median":-10.468381,"eighty":-7.937424,"marketCap":577046353},{"date":"2024-10-11","current":-13.141817,"twenty":-12.215183,"median":-10.579508,"eighty":-7.980207,"marketCap":625642465},{"date":"2024-10-18","current":-14.443716,"twenty":-12.644595,"median":-10.678753,"eighty":-7.993293,"marketCap":687621999},{"date":"2024-10-25","current":-13.155463,"twenty":-12.975228,"median":-10.69616,"eighty":-8.014936,"marketCap":626292146},{"date":"2024-10-31","current":-11.938174,"twenty":-12.976568,"median":-10.764003,"eighty":-8.053188,"marketCap":568340632},{"date":"2024-11-08","current":-18.968977,"twenty":-13.201862,"median":-10.833215,"eighty":-8.053188,"marketCap":903056103},{"date":"2024-11-15","current":-10.699049,"twenty":-13.232134,"median":-10.867118,"eighty":-8.053188,"marketCap":509349629},{"date":"2024-11-22","current":-3.804354,"twenty":-13.201862,"median":-10.811892,"eighty":-8.005373,"marketCap":202570426},{"date":"2024-11-29","current":-7.081932,"twenty":-13.164743,"median":-10.73726,"eighty":-7.916284,"marketCap":377091628},{"date":"2024-12-06","current":-6.123936,"twenty":-13.144546,"median":-10.69616,"eighty":-7.738107,"marketCap":326081199},{"date":"2024-12-13","current":-6.220014,"twenty":-13.009618,"median":-10.678753,"eighty":-7.632912,"marketCap":331197071},{"date":"2024-12-20","current":-6.147607,"twenty":-12.971208,"median":-10.579508,"eighty":-7.59013,"marketCap":327341631},{"date":"2024-12-27","current":-6.711544,"twenty":-12.908645,"median":-10.50763,"eighty":-7.57654,"marketCap":357369573},{"date":"2025-01-03","current":-6.374574,"twenty":-12.853892,"median":-10.405691,"eighty":-7.549864,"marketCap":339426951},{"date":"2025-01-10","current":-5.995231,"twenty":-12.800672,"median":-10.212067,"eighty":-7.505069,"marketCap":319228040},{"date":"2025-01-17","current":-4.918377,"twenty":-12.651961,"median":-10.173232,"eighty":-7.427764,"marketCap":261888801},{"date":"2025-01-24","current":-4.346472,"twenty":-12.574112,"median":-10.030358,"eighty":-7.086806,"marketCap":231436615},{"date":"2025-01-31","current":-4.332524,"twenty":-12.537284,"median":-9.920586,"eighty":-6.842433,"marketCap":230693879},{"date":"2025-02-07","current":-6.50018,"twenty":-12.535901,"median":-9.842528,"eighty":-6.605719,"marketCap":346115092},{"date":"2025-02-14","current":-5.236411,"twenty":-12.52887,"median":-9.777894,"eighty":-6.491539,"marketCap":278823188},{"date":"2025-02-21","current":-4.829104,"twenty":-12.471907,"median":-9.750601,"eighty":-6.430271,"marketCap":257135289},{"date":"2025-02-28","current":-4.770518,"twenty":-12.349943,"median":-9.721942,"eighty":-6.303838,"marketCap":254015797},{"date":"2025-03-07","current":-4.672876,"twenty":-12.236804,"median":-9.661093,"eighty":-6.2189,"marketCap":248816643},{"date":"2025-03-14","current":-4.686825,"twenty":-12.214976,"median":-9.588204,"eighty":-6.130619,"marketCap":249559380},{"date":"2025-03-21","current":-4.24883,"twenty":-12.149292,"median":-9.555425,"eighty":-6.004158,"marketCap":226237461},{"date":"2025-03-28","current":-3.045755,"twenty":-12.12341,"median":-9.468113,"eighty":-5.45457,"marketCap":228870246},{"date":"2025-04-04","current":-1.92123,"twenty":-12.043093,"median":-9.418302,"eighty":-5.225252,"marketCap":144368903},{"date":"2025-04-11","current":-1.782154,"twenty":-12.004592,"median":-9.374415,"eighty":-5.034123,"marketCap":133918207},{"date":"2025-04-17","current":-2.044108,"twenty":-11.997937,"median":-9.328916,"eighty":-4.961897,"marketCap":153602450},{"date":"2025-04-25","current":-2.917172,"twenty":-11.976697,"median":-9.167755,"eighty":-4.922368,"marketCap":219207954},{"date":"2025-05-02","current":-2.922866,"twenty":-11.956745,"median":-9.074937,"eighty":-4.83359,"marketCap":219635816},{"date":"2025-05-09","current":-2.846947,"twenty":-11.943832,"median":-8.430682,"eighty":-4.764939,"marketCap":213930990},{"date":"2025-05-16","current":-3.416053,"twenty":-11.921952,"median":-8.053188,"eighty":-4.703006,"marketCap":276256218},{"date":"2025-05-23","current":-3.181497,"twenty":-11.907794,"median":-8.053188,"eighty":-4.667296,"marketCap":257287670},{"date":"2025-05-30","current":-3.304948,"twenty":-11.891321,"median":-7.997823,"eighty":-4.63103,"marketCap":267271116},{"date":"2025-06-06","current":-4.042124,"twenty":-11.854896,"median":-7.927357,"eighty":-4.432955,"marketCap":326886552},{"date":"2025-06-13","current":-3.597702,"twenty":-11.83216,"median":-7.80656,"eighty":-4.329176,"marketCap":290946146},{"date":"2025-06-20","current":-3.22735,"twenty":-11.824338,"median":-7.733577,"eighty":-4.305184,"marketCap":260995807},{"date":"2025-06-27","current":-2.922251,"twenty":-11.790759,"median":-7.659337,"eighty":-4.202034,"marketCap":236322433},{"date":"2025-07-03","current":-3.543031,"twenty":-11.778088,"median":-7.622846,"eighty":-3.964273,"marketCap":286524905},{"date":"2025-07-11","current":-3.87282,"twenty":-11.778088,"median":-7.593905,"eighty":-3.821676,"marketCap":313194969},{"date":"2025-07-18","current":-3.985689,"twenty":-11.771752,"median":-7.587614,"eighty":-3.805804,"marketCap":322322691},{"date":"2025-07-25","current":-4.022724,"twenty":-11.764996,"median":-7.573772,"eighty":-3.819913,"marketCap":325317725},{"date":"2025-08-01","current":-3.839312,"twenty":-11.670697,"median":-7.549864,"eighty":-3.819913,"marketCap":310485176},{"date":"2025-08-08","current":-3.784641,"twenty":-11.657709,"median":-7.513374,"eighty":-3.804354,"marketCap":306063936},{"date":"2025-08-15","current":-3.416033,"twenty":-11.655175,"median":-7.497015,"eighty":-3.77935,"marketCap":288292703},{"date":"2025-08-22","current":-3.339933,"twenty":-11.654541,"median":-7.373701,"eighty":-3.740907,"marketCap":281870341},{"date":"2025-08-29","current":-3.186043,"twenty":-11.623292,"median":-7.086806,"eighty":-3.597702,"marketCap":268882897},{"date":"2025-09-05","current":-3.316258,"twenty":-11.587469,"median":-7.081932,"eighty":-3.564545,"marketCap":279872272},{"date":"2025-09-12","current":-3.39574,"twenty":-11.537964,"median":-6.776988,"eighty":-3.481558,"marketCap":286580073},{"date":"2025-09-19","current":-3.158985,"twenty":-11.502485,"median":-6.605719,"eighty":-3.434395,"marketCap":266599390},{"date":"2025-09-26","current":-2.943369,"twenty":-11.461109,"median":-6.573692,"eighty":-3.385336,"marketCap":248402697},{"date":"2025-10-03","current":-3.547939,"twenty":-11.450166,"median":-6.491539,"eighty":-3.377814,"marketCap":299424797},{"date":"2025-10-10","current":-5.337129,"twenty":-11.445253,"median":-6.449765,"eighty":-3.380182,"marketCap":450421668},{"date":"2025-10-17","current":-5.748068,"twenty":-11.407188,"median":-6.374574,"eighty":-3.383551,"marketCap":485102424},{"date":"2025-10-24","current":-4.855164,"twenty":-11.397945,"median":-6.302167,"eighty":-3.385336,"marketCap":409746708},{"date":"2025-10-31","current":-5.604324,"twenty":-11.395615,"median":-6.221406,"eighty":-3.393711,"marketCap":472971296},{"date":"2025-11-07","current":-4.508487,"twenty":-11.353547,"median":-6.20957,"eighty":-3.411974,"marketCap":380489280},{"date":"2025-11-14","current":-4.862014,"twenty":-11.286405,"median":-6.13229,"eighty":-3.416049,"marketCap":410324802},{"date":"2025-11-21","current":-3.711875,"twenty":-11.19565,"median":-6.083345,"eighty":-3.434395,"marketCap":315991920},{"date":"2025-11-28","current":-3.835604,"twenty":-11.143862,"median":-6.000811,"eighty":-3.441096,"marketCap":326524984},{"date":"2025-12-05","current":-3.850161,"twenty":-11.110635,"median":-5.793728,"eighty":-3.451989,"marketCap":327764168},{"date":"2025-12-12","current":-3.868356,"twenty":-11.06004,"median":-5.680588,"eighty":-3.464399,"marketCap":329313148},{"date":"2025-12-19","current":-3.508086,"twenty":-11.030846,"median":-5.604324,"eighty":-3.47695,"marketCap":298643344},{"date":"2025-12-26","current":-3.65183,"twenty":-11.024546,"median":-5.462383,"eighty":-3.4835,"marketCap":310880286},{"date":"2026-01-02","current":-3.748266,"twenty":-11.014016,"median":-5.423319,"eighty":-3.488028,"marketCap":319089880},{"date":"2026-01-09","current":-3.398913,"twenty":-11.004191,"median":-5.362496,"eighty":-3.47056,"marketCap":289349464},{"date":"2026-01-16","current":-3.286101,"twenty":-10.982901,"median":-5.337129,"eighty":-3.424394,"marketCap":279745788},{"date":"2026-01-23","current":-3.455319,"twenty":-10.950149,"median":-5.255956,"eighty":-3.416033,"marketCap":294151302},{"date":"2026-01-30","current":-3.437123,"twenty":-10.917397,"median":-5.24669,"eighty":-3.416033,"marketCap":292602322},{"date":"2026-02-06","current":-2.978598,"twenty":-10.901021,"median":-5.220443,"eighty":-3.384309,"marketCap":253568026},{"date":"2026-02-13","current":-3.093229,"twenty":-10.833215,"median":-5.176431,"eighty":-3.360227,"marketCap":263326600},{"date":"2026-02-20","current":-3.387996,"twenty":-10.826322,"median":-5.1238,"eighty":-3.344395,"marketCap":288420076},{"date":"2026-02-27","current":-3.580868,"twenty":-10.814433,"median":-5.042522,"eighty":-3.344395,"marketCap":304839264},{"date":"2026-03-06","current":-4.026657,"twenty":-10.794975,"median":-4.976962,"eighty":-3.351841,"marketCap":342789274},{"date":"2026-03-13","current":-4.057589,"twenty":-10.747957,"median":-4.935115,"eighty":-3.358866,"marketCap":345422540},{"date":"2026-03-20","current":-3.49171,"twenty":-10.706691,"median":-4.921703,"eighty":-3.363519,"marketCap":297249262},{"date":"2026-03-27","current":-3.690558,"twenty":-10.698793,"median":-4.862014,"eighty":-3.371873,"marketCap":333445613},{"date":"2026-04-02","current":-3.733652,"twenty":-10.695646,"median":-4.843053,"eighty":-3.36999,"marketCap":337339186},{"date":"2026-04-10","current":-3.683663,"twenty":-10.688456,"median":-4.832842,"eighty":-3.3768,"marketCap":332822641},{"date":"2026-04-17","current":-4.417982,"twenty":-10.681265,"median":-4.798416,"eighty":-3.3768,"marketCap":399169129},{"date":"2026-04-24","current":-4.657895,"twenty":-10.639691,"median":-4.783762,"eighty":-3.379844,"marketCap":420845432},{"date":"2026-05-01","current":-4.509257,"twenty":-10.598077,"median":-4.75657,"eighty":-3.382793,"marketCap":407415856},{"date":"2026-05-08","current":-5.402812,"twenty":-10.577871,"median":-4.776107,"eighty":-3.385079,"marketCap":488149470},{"date":"2026-05-15","current":-5.009484,"twenty":-10.556655,"median":-4.798416,"eighty":-3.387035,"marketCap":494125444},{"date":"2026-05-22","current":-4.423148,"twenty":-10.49978,"median":-4.779444,"eighty":-3.392642,"marketCap":436290486},{"date":"2026-05-29","current":-4.405526,"twenty":-10.464613,"median":-4.763544,"eighty":-3.397009,"marketCap":434552277},{"date":"2026-06-05","current":-4.402322,"twenty":-10.416345,"median":-4.734251,"eighty":-3.405761,"marketCap":434236239},{"date":"2026-06-12","current":-4.645827,"twenty":-10.296743,"median":-4.709778,"eighty":-3.416041,"marketCap":458255129},{"date":"2026-06-18","current":-4.932587,"twenty":-10.212762,"median":-4.709778,"eighty":-3.416992,"marketCap":486540531},{"date":"2026-06-26","current":-4.871711,"twenty":-10.209654,"median":-4.734251,"eighty":-3.424023,"marketCap":480535809},{"date":"2026-07-02","current":-5.427608,"twenty":-10.20463,"median":-4.75657,"eighty":-3.437123,"marketCap":535368405},{"date":"2026-07-10","current":-8.654559,"twenty":-10.173232,"median":-4.779444,"eighty":-3.438943,"marketCap":853668396},{"date":"2026-07-17","current":-7.373749,"twenty":-10.082175,"median":-4.785829,"eighty":-3.43898,"marketCap":727331850},{"date":"2026-07-24","current":-7.18587,"twenty":-10.030358,"median":-4.808949,"eighty":-3.442507,"marketCap":708799833},{"date":"2026-07-31","current":-6.787889,"twenty":-9.971335,"median":-4.824919,"eighty":-3.452757,"marketCap":669543840},{"date":"2026-08-07","current":-7.19193,"twenty":-9.939181,"median":-4.840263,"eighty":-3.457713,"marketCap":709397640},{"date":"2026-08-14","current":-6.417114,"twenty":-9.912039,"median":-4.858589,"eighty":-3.464651,"marketCap":713005540},{"date":"2026-08-21","current":-6.84216,"twenty":-9.89127,"median":-4.877395,"eighty":-3.468013,"marketCap":760232402}],"updateTime":1787645469065},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NGNE\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2647936375","title":"Neurogene Reports Positive Long-term Clinical Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2647936375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647936375?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1LLC8W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647119375","title":"Neurogene - Ngn-401 Generally Well-tolerated at 1E15 Vg Dose as of June 16, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647119375","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647119375?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:00","pubTimestamp":1782730800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nTUA1LLC8W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289034","title":"Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) and Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289034","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289034?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:21","pubTimestamp":1781176915,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Abbott Laboratories (ABT), HeartFlow, Inc. (HTFL) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-heartflow-inc-htfl-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-abbott-laboratories-abt-heartflow-inc-htfl-and-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU1691799644.USD","LU1989763690.USD","SG9999002224.SGD","SGXZ41872573.SGD","XBI","LU0170899867.USD","LU2324357040.USD","BK4568","BK4137","LU1023059063.AUD","LU0128526141.USD","LU0266013472.USD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4082","SG9999002232.USD","LU2211815571.USD","LABU","LU0058720904.USD","HTFL","LU2237957811.SGD","LU0289739699.SGD","BK4566","LU0868494617.USD","LU2133065610.SGD","XLV","BK4139","SGXZ23171101.USD","LU1721429402.USD","SG9999004303.SGD","LU0122379950.USD","LU1914381329.SGD","ABT","IE00BFTCPJ56.SGD","BK4504","HCSG","IE0009355771.USD","LU2089984988.USD","LU2112291526.USD","IE00BJJMRZ35.SGD","LU1989763427.SGD","BK4533","IE00B2B36J28.USD","BK4167","BK4581","IE00BJT1NW94.SGD","LU1057294990.SGD","LU1061106388.HKD","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642461178","title":"Neurogene Price Target Maintained With a $70.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2642461178","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642461178?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:37","pubTimestamp":1781001420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NGNE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 09, 2026 06:37 ET (10:37 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641381814","title":"Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Lyell Immunopharma (LYEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641381814","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641381814?lang=en_us&edition=fundamental","pubTime":"2026-06-08 23:20","pubTimestamp":1780932007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Neurogene (NGNE) and Lyell Immunopharma (LYEL) with ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-neurogene-ngne-and-lyell-immunopharma-lyel-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","LABU","BK4581","XLV","BK4139","BK4588","LYEL","XBI","HCSG","BK4585","BK4539","LU0128526141.USD","LU0029874061.USD","BK4505","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484088","title":"Neurogene Completes Enrollment in Embolden Trial of NGN-401","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484088","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484088?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:54","pubTimestamp":1780923272,"startTime":"0","endTime":"0","summary":"Neurogene (NGNE) has completed dosing in the Embolden registrational trial of NGN-401 for Rett syndrome, exceeding its initial target by enrolling 25 participants, the company said Monday.Neurogene sa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641148914","title":"Neurogene - Topline Data From Embolden Trial Anticipated in Second Half of 2027 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2641148914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641148914?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:33","pubTimestamp":1780918431,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nFWN42G0HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641448994","title":"Neurogene Announces Successful Completion of Dosing in Embolden™ Registrational Trial of Ngn-401 for Rett Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2641448994","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641448994?lang=en_us&edition=fundamental","pubTime":"2026-06-08 19:30","pubTimestamp":1780918200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUABQSQBK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641167579","title":"Neurogene shareholders elect Baffi, Palekar as Class III directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641167579","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641167579?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:41","pubTimestamp":1780605710,"startTime":"0","endTime":"0","summary":"Neurogene held its annual shareholder meeting on June 3, 2026.Shareholders backed the selection of Robert Baffi, Rohan Palekar as Class III directors, with terms running to the 2029 annual meeting.A non-binding vote favored holding future say-on-pay votes annually; the board plans to follow that schedule unless it later changes course.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL5ZppMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640909202","title":"Neurogene initiated with a Buy at Rodman & Renshaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2640909202","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640909202?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:38","pubTimestamp":1780486726,"startTime":"0","endTime":"0","summary":"Rodman & Renshaw initiated coverage of Neurogene (NGNE) with a Buy rating and $70 price target implying 170% upside from current levels. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurogene-initiated-with-a-buy-at-rodman-renshaw-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurogene-initiated-with-a-buy-at-rodman-renshaw-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640923922","title":"Neurogene issues inducement stock options for 17,045 shares to new hires","url":"https://stock-news.laohu8.com/highlight/detail?id=2640923922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640923922?lang=en_us&edition=fundamental","pubTime":"2026-06-03 04:01","pubTimestamp":1780430483,"startTime":"0","endTime":"0","summary":"Neurogene granted non-qualified stock options covering 17,045 common shares to two new employees on June 1, 2026.Exercise price set at the stock’s June 1 closing price.Options vest over four years: 25% on the first anniversary, then monthly in equal installments over the next three years.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. published the original content used to generate this news brief via Business Wire  on June 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDLc8VxPh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854459","title":"Analysts Offer Insights on Healthcare Companies: Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and Milestone Pharmaceuticals (MIST)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638854459?lang=en_us&edition=fundamental","pubTime":"2026-05-27 02:00","pubTimestamp":1779818430,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alpha Tau Medical Ltd (DRTS), Neurogene (NGNE) and M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-tau-medical-ltd-drts-neurogene-ngne-and-milestone-pharmaceuticals-mist-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-tau-medical-ltd-drts-neurogene-ngne-and-milestone-pharmaceuticals-mist-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4581","NGNE","DRTS","MIST","XLV","HCSG","LU0128526141.USD","LU0029874061.USD","BK4585","BK4007","BK4082","BK4137","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635066526","title":"LifeSci Capital Sticks to Its Buy Rating for Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635066526","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635066526?lang=en_us&edition=fundamental","pubTime":"2026-05-16 22:36","pubTimestamp":1778942210,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Patrick Dolezal maintained a Buy rating on Neurogene today and set a price target of $60.00. Dolezal covers the Healthcare ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lifesci-capital-sticks-to-its-buy-rating-for-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635787121","title":"Analysts Are Bullish on Top Healthcare Stocks: Acurx Pharmaceuticals (ACXP), Neurogene (NGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635787121","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635787121?lang=en_us&edition=fundamental","pubTime":"2026-05-13 21:00","pubTimestamp":1778677245,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Acurx Pharmaceuticals (ACXP) and Neurogene (NGNE) wi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-acurx-pharmaceuticals-acxp-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-acurx-pharmaceuticals-acxp-neurogene-ngne-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","BLSG","BK4563","LABU","XBI","BLSX","BK4581","LU0029874061.USD","NGNE","ACXP","LU0128526141.USD","BK4137","BK4539","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635303784","title":"Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (STXS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635303784","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635303784?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:00","pubTimestamp":1778673636,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Pharvaris (PHVS), Neurogene (NGNE) and Stereotaxis (...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-neurogene-ngne-and-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-pharvaris-phvs-neurogene-ngne-and-stereotaxis-stxs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NGNE","BK4585","LU0029874061.USD","HCSG","XBI","STXS","BK4137","BK4581","XLV","BK4139","PHVS","LABU","BK4588","BK4007","BK4082","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635223321","title":"Neurogene Q1 EPS $(1.39) Misses $(1.36) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635223321","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635223321?lang=en_us&edition=fundamental","pubTime":"2026-05-13 05:06","pubTimestamp":1778619979,"startTime":"0","endTime":"0","summary":"Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.39) per share which missed the analyst consensus estimate of $(1.36) by 2.21 percent. This is a 28.7 percent decrease over losses of $(1.08) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52508888/neurogene-q1-eps-1-39-misses-1-36-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurogene Q1 EPS $(1.39) Misses $(1.36) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635222850","title":"Neurogene posts corporate deck highlighting NGN-401 gene therapy program for Rett syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2635222850","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635222850?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:41","pubTimestamp":1778618494,"startTime":"0","endTime":"0","summary":"Neurogene highlighted NGN-401 as a one-time gene therapy candidate for Rett syndrome, supported by interim Phase 1/2 data showing functional improvements across core domains in 100% of participants, with 35 total developmental milestones gained and no plateau reported out to 24 months.Safety profile at 1E15 vg dose described as generally well tolerated in 10 participants, with treatment-emergent adverse events related to NGN-401 limited to Grade 1 or Grade 2; most participants had mild liver enzyme elevations.Registration plan centers on Embolden, a single-arm, baseline-controlled, open-label trial in females aged ≥3 years  using a responder-based composite endpoint at 12 months; success threshold set at 35%, or 7 of 20 participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpret","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL3sVGsT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NGNE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635247714","title":"Neurogene Q1 net loss widens on higher R&D costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2635247714","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635247714?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:13","pubTimestamp":1778616821,"startTime":"0","endTime":"0","summary":"Neurogene Q1 net loss widens on higher R&D costsOverviewU.S. gene therapy developer's Q1 net loss widened due to higher R&D expensesCompany has dosed ~90% of participants in Embolden trial for Rett sy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nL1N41P1D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635471682","title":"Neurogene Q1 FY26 net loss widens to USD 30.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635471682","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635471682?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:08","pubTimestamp":1778616537,"startTime":"0","endTime":"0","summary":"Neurogene posted a Q1 net loss of USD 30.9 million, widening from USD 22.6 million a year earlier, with loss per share deepening to USD 1.39 from USD 1.08.R&D expense rose to USD 25.2 million from USD 17.8 million, while G&A expense was little changed at USD 8.2 million.Cash, cash equivalents, short-term investments totaled USD 243.2 million as of March 31, expected to fund operations through Q1 2028.About 90% of participants have been dosed in Embolden registrational trial for Rett syndrome gene therapy NGN-401, with dosing on track to finish in Q2 2026.NGN-401 at 1E15 vg has been generally well-tolerated, with no HLH cases reported in Phase 1/2 or Embolden as of May 11.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurogene Inc. pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nNDL9GSTWr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635475972","title":"BRIEF-Neurogene Q1 Operating Expenses USD 33.349 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635475972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635475972?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616346,"startTime":"0","endTime":"0","summary":"BRIEF-Neurogene Q1 Operating Expenses USD 33.349 Million\n\n\nMay 12 (Reuters) - Neurogene Q1 operating income USD -33.349 million.\n\nQ1 net income USD -30.934 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nPLXB88F00:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NGNE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":3,"totalSize":108,"code":"91000000","status":"200"}]}}